15 Days Price Change
Closing In
WEBSITE Inc. Year: 1995 Industry: Pharmaceuticals & Drugs Listed Page
Buy unlisted shares early and participate in the growth before public listing.
Face Value 10 per share
Price 32 to 34 per share
P/E (x) 9.2
Sales( Cr.) 38
PAT( Cr.) 4
EPS 3.7
Draft Prospectus --
Exchange NSE-SME
Company Promoters
Pre Issue Share Holding 100%
Post Issue Share Holding 42.49%
Listing Price: 137.85
Listing Gain: 75.34%
Current Price: 24
Gain On Issue: 24 | 0%
GMP: --
GMP %: -- %
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | 136,000 |
| Retail (Max) | 1 | 4000 | 136,000 |
| S-HNI (Min) | 2 | 8000 | 272,000 |
| S-HNI (Max) | 7 | 28000 | 952,000 |
| B-HNI (Min) | 8 | 32000 | 1,088,000 |
1. Funding of expenses proposed to be incurred towards Product registration in the international markets. 2. Plant updation and increase in production capacity Funding working capital requirements of our Company. 3. General Corporate Purposes.
| Category | Nos | Bid | Bid (x) |
|---|---|---|---|
| QIB | 1550000 | 268196500 | 173x |
| NII | 465000 | 624880950 | 1343.8x |
| Retail | 1085000 | 1421100450 | 1309.8x |
| EMP | 0 | 0 | 0x |
| Total | 3100000 | 3080036000 | 993.6x |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 52% | 0% | 0% | 0% |
| Operating Profit CAGR | 17% | 0% | 0% | 0% |
| PAT CAGR | 33% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -35% | NA% | NA% | NA% |
| ROE Average | 18% | 18% | 18% | 18% |
| ROCE Average | 17% | 18% | 18% | 18% |
Medicamen Organics Ltd.
10 Community Centre No 2 Ashok Vihar Phase I I
Medicamen Organics Ltd.
GYR Capital Advisors Pvt Ltd.
Medicamen Organics Ltd.
When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.
For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.
Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.
Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.
Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.
ChatGPT
Claude
Perplexity
